Advertisement

Nutrition Management in Childhood Kidney Disease: an Integrative and Lifecourse Approach

  • Lauren Graf
  • Kimberly Reidy
  • Frederick J. Kaskel
Living reference work entry

Abstract

Infants, children, and adolescents with chronic kidney disease (CKD), end-stage renal disease (ESRD), and kidney disorders such as nephrotic syndrome face unique nutritional challenges. The goals of this chapter are to outline the nutritional problems associated with various forms of kidney disease and describe interventions to correct them. The approach to nutritional management varies greatly based on the age of the child and type of kidney disorder. The primary goals of nutrition in infants and young children with CKD are to promote adequate weight gain, linear growth, and hydration as well as maintain electrolyte homeostasis. For older children and teenagers with CKD and ESRD, the traditional nutritional goals have focused on the management of potassium and phosphorus, fluid balance, and growth. However, as our understanding of nutrition evolved, it is now recognized that diet (quantity and quality of food) has far-reaching effects on overall health. Nutrition is extremely important in modulating inflammation, immune function, and the gut microbiome, all of which play a major role in preventing chronic diseases including cardiovascular disease (CVD) and cancer. A large body of research over the past decade has led to a paradigm shift in nutrition and kidney disease. The recommendations for protein intake in the ESRD population as well as the most effective way to manage dietary phosphorus have changed dramatically. In addition, in some cases of idiopathic nephrotic syndrome, diet therapy has been effective as a treatment of the disease rather than simply managing symptoms. The following sections will identify nutritional problems in various kidney disorders and describe the diet therapy to best help manage them.

Keywords

Chronic Kidney Disease Nephrotic Syndrome Coronary Artery Calcification Serum Phosphorus Idiopathic Nephrotic Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Ingulli EG, Mak RH. Growth in children with chronic kidney disease: role of nutrition, growth hormone, dialysis, and steroids. Curr Opin Pediatr. 2014;26(2):187–92.CrossRefPubMedGoogle Scholar
  2. 2.
    Graf L, et al. Nutrition assessment and hormonal influences on body composition in children with chronic kidney disease. Adv Chronic Kidney Dis. 2007;14(2):215–23.CrossRefPubMedGoogle Scholar
  3. 3.
    Foster BJ, McCauley L, Mak RH. Nutrition in infants and very young children with chronic kidney disease. Pediatr Nephrol. 2012;27(9):1427–39.CrossRefPubMedGoogle Scholar
  4. 4.
    Group KW. KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update. Executive summary. Am J Kidney Dis. 2009;53(3 Suppl 2):S11–104.Google Scholar
  5. 5.
    Bunchman TE. Nutritional delivery in infants with CKD: techniques to avoid hyperkalemia. J Ren Nutr. 2013;23(5):387–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Thompson K, et al. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate((R))) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency. J Ren Nutr. 2013;23(5):333–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Kovacs CS. Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones. Physiol Rev. 2014;94(4):1143–218.CrossRefPubMedGoogle Scholar
  8. 8.
    Kovacs CS. Bone metabolism in the fetus and neonate. Pediatr Nephrol. 2014;29(5):793–803.CrossRefPubMedGoogle Scholar
  9. 9.
    Abrams SA. Calcium and vitamin d requirements of enterally fed preterm infants. Pediatrics. 2013;131(5):e1676–83.CrossRefPubMedGoogle Scholar
  10. 10.
    Hicks PD, et al. Total calcium absorption is similar from infant formulas with and without prebiotics and exceeds that in human milk-fed infants. BMC Pediatr. 2012;12:118.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Alon U, Chan JCM. Phosphate in pediatric health and disease. Boca Raton: CRC Press; 1993. p. 327.Google Scholar
  12. 12.
    Bailey DA, et al. Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res. 2000;15(11):2245–50.CrossRefPubMedGoogle Scholar
  13. 13.
    Karlen J, Aperia A, Zetterstrom R. Renal excretion of calcium and phosphate in preterm and term infants. J Pediatr. 1985;106(5):814–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Aladangady N, et al. Urinary excretion of calcium and phosphate in preterm infants. Pediatr Nephrol. 2004;19(11):1225–31.CrossRefPubMedGoogle Scholar
  15. 15.
    In: Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press; 1997.Google Scholar
  16. 16.
    Gattineni J, Baum M. Developmental changes in renal tubular transport-an overview. Pediatr Nephrol. 2013.Google Scholar
  17. 17.
    Takaiwa M, et al. Fibroblast growth factor 23 concentrations in healthy term infants during the early postpartum period. Bone. 2010;47(2):256–62.CrossRefGoogle Scholar
  18. 18.
    Raaijmakers R, et al. Pre-treatment of dairy and breast milk with sevelamer hydrochloride and sevelamer carbonate to reduce phosphate. Perit Dial Int. 2013;33(5):565–72.PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Parekh RS, et al. Improved growth in young children with severe chronic renal insufficiency who use specified nutritional therapy. J Am Soc Nephrol. 2001;12(11):2418–26.PubMedGoogle Scholar
  20. 20.
    Ivanova E, et al. Cystinosis: clinical presentation, pathogenesis and treatment. Pediatr Endocrinol Rev. 2014;12 Suppl 1:176–84.PubMedGoogle Scholar
  21. 21.
    Nesterova G, et al. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy. Pediatr Nephrol. 2014.Google Scholar
  22. 22.
    Meyer KB, Levey AS. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on Cardiovascular Disease. J Am Soc Nephrol. 1998;9(12 Suppl):S31–42.PubMedGoogle Scholar
  23. 23.
    Foster BJ, et al. Change in mortality risk over time in young kidney transplant recipients. Am J Transplant. 2011;11(11):2432–42.CrossRefPubMedGoogle Scholar
  24. 24.
    Mitsnefes MM. Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol. 2012;23(4):578–85.PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    Flynn JT, et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension. 2008;52(4):631–7.PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Saland JM, et al. Dyslipidemia in children with chronic kidney disease. Kidney Int. 2010;78(11):1154–63.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Oh J, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106(1):100–5.CrossRefPubMedGoogle Scholar
  28. 28.
    Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Shroff R, et al. HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype. J Am Soc Nephrol. 2014;25(11):2658–68.CrossRefPubMedGoogle Scholar
  30. 30.
    Evenepoel P, Meijers BK. Dietary fiber and protein: nutritional therapy in chronic kidney disease and beyond. Kidney Int. 2012;81(3):227–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Uribarri J, Oh MS. The key to halting progression of CKD might be in the produce market, not in the pharmacy. Kidney Int. 2012;81(1):7–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Cordain L, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81(2):341–54.PubMedGoogle Scholar
  33. 33.
    Tuso PJ, et al. Nutritional update for physicians: plant-based diets. Perm J. 2013;17(2):61–6.PubMedCentralCrossRefPubMedGoogle Scholar
  34. 34.
    Krishnamurthy VM, et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int. 2012;81(3):300–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014;25(4):657–70.PubMedCentralCrossRefPubMedGoogle Scholar
  36. 36.
    Brown K, et al. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012;4(8):1095–119.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    De Filippo C, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107(33):14691–6.PubMedCentralCrossRefPubMedGoogle Scholar
  38. 38.
    Vaziri ND, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013;83(2):308–15.CrossRefPubMedGoogle Scholar
  39. 39.
    Niwa T. Indoxyl sulfate is a nephro-vascular toxin. J Ren Nutr. 2010;20(5 Suppl):S2–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Evenepoel P, et al. Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl. 2009;114:S12–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Vanholder R, et al. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol. 2014;25(9):1897–907.CrossRefPubMedGoogle Scholar
  42. 42.
    Moe SM, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(2):257–64.PubMedCentralCrossRefPubMedGoogle Scholar
  43. 43.
    Noori N, et al. Organic and inorganic dietary phosphorus and its management in chronic kidney disease. Iran J Kidney Dis. 2010;4(2):89–100.PubMedGoogle Scholar
  44. 44.
    Fukagawa M, Komaba H, Miyamoto K. Source matters: from phosphorus load to bioavailability. Clin J Am Soc Nephrol. 2011;6(2):239–40.CrossRefPubMedGoogle Scholar
  45. 45.
    Kalantar-Zadeh K, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(3):519–30.CrossRefPubMedGoogle Scholar
  46. 46.
    Gutierrez OM, et al. Dietary patterns and risk of death and progression to ESRD in individuals with CKD: a cohort study. Am J Kidney Dis. 2014;64(2):204–13.PubMedCentralCrossRefPubMedGoogle Scholar
  47. 47.
    Dekker MJ, et al. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab. 2010;299(5):E685–94.CrossRefPubMedGoogle Scholar
  48. 48.
    Carvalho CR, et al. Fructose alters adiponectin, haptoglobin and angiotensinogen gene expression in 3T3-L1 adipocytes. Nutr Res. 2010;30(9):644–9.CrossRefPubMedGoogle Scholar
  49. 49.
    Johnson RJ, Sanchez-Lozada LG, Nakagawa T. The effect of fructose on renal biology and disease. J Am Soc Nephrol. 2010;21(12):2036–9.CrossRefPubMedGoogle Scholar
  50. 50.
    Khitan Z, Kim DH. Fructose: a key factor in the development of metabolic syndrome and hypertension. J Nutr Metab. 2013;2013:682673.PubMedCentralCrossRefPubMedGoogle Scholar
  51. 51.
    Madero M, et al. Dietary fructose and hypertension. Curr Hypertens Rep. 2011;13(1):29–35.CrossRefPubMedGoogle Scholar
  52. 52.
    DiNicolantonio JJ, O’Keefe JH, Lucan SC. An unsavory truth: sugar, more than salt, predisposes to hypertension and chronic disease. Am J Cardiol. 2014;114(7):1126–8.CrossRefPubMedGoogle Scholar
  53. 53.
    Shroff R. Phosphate is a vascular toxin. Pediatr Nephrol. 2013;28(4):583–93.CrossRefPubMedGoogle Scholar
  54. 54.
    Shuto E, et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol. 2009;20(7):1504–12.PubMedCentralCrossRefPubMedGoogle Scholar
  55. 55.
    Tonelli M, et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112(17):2627–33.CrossRefPubMedGoogle Scholar
  56. 56.
    Chang AR, et al. High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr. 2014;99(2):320–7.PubMedCentralCrossRefPubMedGoogle Scholar
  57. 57.
    Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr. 2007;17(5):350–4.PubMedCentralCrossRefPubMedGoogle Scholar
  58. 58.
    Uribarri J. Phosphorus additives in food and their effect in dialysis patients. Clin J Am Soc Nephrol. 2009;4(8):1290–2.CrossRefPubMedGoogle Scholar
  59. 59.
    Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4(8):1370–3.PubMedCentralCrossRefPubMedGoogle Scholar
  60. 60.
    Azocar MA, et al. Body composition in children on peritoneal dialysis. Adv Perit Dial. 2004;20:231–6.PubMedGoogle Scholar
  61. 61.
    Quan A, Baum M. Protein losses in children on continuous cycler peritoneal dialysis. Pediatr Nephrol. 1996;10(6):728–31.CrossRefPubMedGoogle Scholar
  62. 62.
    Uribarri J. The obsession with high dietary protein intake in ESRD patients on dialysis: is it justified? Nephron. 2000;86(2):105–8.CrossRefPubMedGoogle Scholar
  63. 63.
    Wolfson M, Jones MR, Kopple JD. Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int. 1982;21(3):500–6.CrossRefPubMedGoogle Scholar
  64. 64.
    Chazot C, et al. Dialytic nutrition: provision of amino acids in dialysate during hemodialysis. Kidney Int. 1997;52(6):1663–70.CrossRefPubMedGoogle Scholar
  65. 65.
    Ikizler TA, et al. Amino acid and albumin losses during hemodialysis. Kidney Int. 1994;46(3):830–7.CrossRefPubMedGoogle Scholar
  66. 66.
    Canepa A, et al. Long-term effect of amino-acid dialysis solution in children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol. 1991;5(2):215–9.CrossRefPubMedGoogle Scholar
  67. 67.
    Canepa A, et al. Continuous ambulatory peritoneal dialysis (CAPD) of children with amino acid solutions: technical and metabolic aspects. Perit Dial Int. 1990;10(3):215–20.PubMedGoogle Scholar
  68. 68.
    Hanning RM, Balfe JW, Zlotkin SH. Effectiveness and nutritional consequences of amino acid-based vs glucose-based dialysis solutions in infants and children receiving CAPD. Am J Clin Nutr. 1987;46(1):22–30.PubMedGoogle Scholar
  69. 69.
    Qamar IU, et al. Effects of 3-month amino acid dialysis compared to dextrose dialysis in children on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1994;14(1):34–41.PubMedGoogle Scholar
  70. 70.
    Qamar IU, et al. Effects of amino acid dialysis compared to dextrose dialysis in children on continuous cycling peritoneal dialysis. Perit Dial Int. 1999;19(3):237–47.PubMedGoogle Scholar
  71. 71.
    Goraya N, et al. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013;8(3):371–81.PubMedCentralCrossRefPubMedGoogle Scholar
  72. 72.
    Goraya N, et al. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int. 2012;81(1):86–93.CrossRefPubMedGoogle Scholar
  73. 73.
    Nevin KG, Rajamohan T. Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation. Clin Biochem. 2004;37(9):830–5.CrossRefPubMedGoogle Scholar
  74. 74.
    Noori N, et al. Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. Am J Kidney Dis. 2011;58(2):248–56.PubMedCentralCrossRefPubMedGoogle Scholar
  75. 75.
    Uy N, et al. Effects of gluten-free, dairy-free diet on childhood nephrotic syndrome and gut microbiota. Pediatr Res. 2014;77:252.CrossRefPubMedGoogle Scholar
  76. 76.
    Sandberg DH, et al. Severe steroid-responsive nephrosis associated with hypersensitivity. Lancet. 1977;1(8008):388–91.CrossRefPubMedGoogle Scholar
  77. 77.
    Laurent J, Lagrue G. Dietary manipulation for idiopathic nephrotic syndrome. A new approach to therapy. Allergy. 1989;44(8):599–603.CrossRefPubMedGoogle Scholar
  78. 78.
    Sieniawska M, et al. The role of cow’s milk protein intolerance in steroid-resistant nephrotic syndrome. Acta Paediatr. 1992;81(12):1007–12.CrossRefPubMedGoogle Scholar
  79. 79.
    de Sousa JS, et al. Cow’s milk protein sensitivity: a possible cause of nephrotic syndrome in early infancy. J Pediatr Gastroenterol Nutr. 1995;21(2):235–7.CrossRefPubMedGoogle Scholar
  80. 80.
    Rasoulpour M, Dalidowitz C. 170: resolution of steroid-dependency by a dairy/hypoallergenic diet in children with nephrotic syndrome. Am J Kidney Dis. 2007;49(4):B67.CrossRefGoogle Scholar
  81. 81.
    Skripak JM, et al. The natural history of IgE-mediated cow’s milk allergy. J Allergy Clin Immunol. 2007;120(5):1172–7.CrossRefPubMedGoogle Scholar
  82. 82.
    Wood RA. The natural history of food allergy. Pediatrics. 2003;111(6 Pt 3):1631–7.PubMedGoogle Scholar
  83. 83.
    Mansueto P, et al. Non-celiac gluten sensitivity: literature review. J Am Coll Nutr. 2014;33(1):39–54.CrossRefPubMedGoogle Scholar
  84. 84.
    Kaskel F, et al. Improving CKD therapies and care: a national dialogue. Clin J Am Soc Nephrol. 2014;9(4):815–7.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg (outside the USA) 2015

Authors and Affiliations

  • Lauren Graf
    • 1
  • Kimberly Reidy
    • 2
  • Frederick J. Kaskel
    • 2
  1. 1.Children’s Hospital at Montefiore, Albert Einstein College of MedicineBronxUSA
  2. 2.Division of Pediatric NephrologyChildren’s Hospital at Montefiore, Albert Einstein College of MedicineBronxUSA

Personalised recommendations